Legal Status Overview
Gray AreaNew Hampshire has no peptide-specific law, administrative rule, or Board of Pharmacy bulletin naming BPC-157, TB-500, GLP-1 peptides, or 'research chemicals' as a distinct legal category. Pharmacy practice and compounding in the state are governed by RSA 318 (the Pharmacy Practice Act) and the Board of Pharmacy's administrative rules, which incorporate the federal 503A/503B compounding framework and USP compounding standards rather than creating a separate New Hampshire peptide rule. As a result, whether a given peptide is lawful to possess, prescribe, or sell in New Hampshire turns on federal drug-approval and compounding law (FDA), not on any distinct New Hampshire text.
Key Points
- New Hampshire has not enacted any statute or Board of Pharmacy administrative rule that names peptides, 'research chemicals,' or research-use-only compounds as a distinct regulated category, so general pharmacy and drug law controls. [1]
- New Hampshire pharmacy practice, including compounding, is governed by RSA 318 (the Pharmacy Practice Act), administered by the New Hampshire Board of Pharmacy under the Office of Professional Licensure and Certification. [1]
- Compounded drugs in New Hampshire, including any compounded peptide products such as BPC-157 or semaglutide preparations, are subject to the federal 503A (traditional compounding pharmacy) and 503B (outsourcing facility) framework enforced by the FDA, which New Hampshire pharmacy regulation relies on rather than replacing. [2]
- The FDA's Pharmacy Compounding Advisory Committee evaluated BPC-157 for the 503A bulks list and found it posed safety risks, recommending it not be added to the list of bulk substances that may be compounded, which limits lawful compounding of BPC-157 nationwide, including in New Hampshire. [3]
- The FDA removed semaglutide and tirzepatide from its drug shortage lists in 2024, which under federal compounding law restricts 503A and 503B pharmacies -- including those operating in New Hampshire -- from mass-compounding copies of these GLP-1 drugs except in narrow circumstances such as documented clinical need. [4]
- Human growth hormone (somatropin) is a prescription-only drug under federal law, and distributing or possessing it without a valid prescription for a medically recognized purpose is a federal crime under 21 U.S.C. section 333(e), a rule that applies in New Hampshire as in every other state because New Hampshire has no separate HGH statute. [5]
- Traveling into or buying peptides in New Hampshire without a prescription is not addressed by any New Hampshire-specific travel or importation statute; the legal pathway to obtain FDA-approved peptide drugs (such as prescription semaglutide or somatropin) in the state is through a licensed prescriber and a New Hampshire-licensed or federally compliant pharmacy, while unapproved research-use-only peptides are not lawfully sold for human use under FDA rules nationwide. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
- No New Hampshire legislative bill or Attorney General guidance specifically addressing peptides, research chemicals, or compounded GLP-1/BPC-157-type products was identified as having been introduced or issued in the last several years. (No reliable source found for this point — flagged as unverified rather than stated as fact.)
Peptide-by-peptide status in New Hampshire
| BPC-157 | BPC-157 has no New Hampshire-specific legal status and is not FDA-approved for any human use, and FDA's compounding advisory committee has flagged it as unsafe for the bulk drug substances compounding list, meaning it exists in a federal regulatory gray zone in New Hampshire as elsewhere. [3] |
|---|---|
| Semaglutide / Tirzepatide (GLP-1 class) | Semaglutide and tirzepatide are legal in New Hampshire only as FDA-approved prescription medicines (e.g., Ozempic, Wegovy, Mounjaro, Zepbound), and since the FDA resolved the national shortage in 2024 the ability of New Hampshire compounding pharmacies to sell non-FDA-approved copies has been significantly restricted under federal law. [4] |
| TB-500 | TB-500 is not FDA-approved for any human use and has no New Hampshire-specific statute addressing it, so no licensed pathway currently exists to lawfully sell or prescribe it for human use in the state. |
| HGH (Human Growth Hormone / Somatropin) | Human growth hormone is legal in New Hampshire only with a valid prescription for an FDA-approved indication, because federal law makes distribution of HGH for unapproved uses (such as bodybuilding or anti-aging) a criminal offense regardless of state. [5] |
Sources
Last researched: 2026-10-02
Frequently asked questions
Can I buy peptides in New Hampshire without a prescription?
Buying FDA-approved peptide drugs such as prescription semaglutide or somatropin in New Hampshire without a prescription is not lawful, and unapproved 'research chemical' peptides like BPC-157 or TB-500 are not legally sold for human consumption under FDA rules that apply statewide; New Hampshire has no separate rule loosening or tightening this. [4]
Is it legal to get peptides prescribed online or via telehealth in New Hampshire?
New Hampshire allows telehealth prescribing under its general telemedicine and Board of Medicine/Board of Pharmacy rules, so a New Hampshire-licensed (or appropriately credentialed) prescriber can lawfully prescribe an FDA-approved peptide drug like semaglutide via telehealth, but this does not extend to unapproved research peptides, which no prescriber can legally prescribe for human use.
What happens if I'm caught with BPC-157 or other research peptides in New Hampshire?
There is no New Hampshire-specific criminal penalty naming BPC-157 or similar peptides, so enforcement in the state would most likely proceed, if at all, under general federal FDA misbranding/unapproved-new-drug authority or consumer-protection law rather than a state peptide-specific charge.
Does New Hampshire regulate compounded semaglutide or tirzepatide differently from other states?
No, New Hampshire does not have its own distinct rule for compounded GLP-1 drugs; compounding pharmacies licensed in New Hampshire must follow the same federal 503A/503B rules and FDA shortage determinations that apply nationally, which now limit mass compounding of semaglutide and tirzepatide since the FDA ended the shortage designation in 2024. [4]
Is human growth hormone (HGH) legal to buy in New Hampshire for anti-aging or bodybuilding use?
No, buying or distributing HGH in New Hampshire for anti-aging, bodybuilding, or other unapproved uses is illegal because federal law specifically criminalizes distribution of human growth hormone for any use not approved by the FDA, and New Hampshire has not created an exception to this. [5]